TARGETED

ANTIMICROBIALS

DISARMING DANGEROUS PATHOGENS

ABOUT NOVOBIND

NovoBind is an integrated animal health company utilizing next-generation biologics to target and neutralize key pathogens affecting producers and food safety.   We target pathogens that cause >$1B of production losses and have been materially affected by the following:

  1. Antibacterial resistance,

  2. A Regulatory ban on antibiotics, and;

  3. Changing consumer sentiment.

 

We are continually expanding our portfolio and are currently focused on:

  1. Aquaculture,

  2. Companion animals,

  3. Food Safety, and;

  4. Poultry.

 
 
CAREERS
CAREERS

We are continually expanding the team with exceptional, passionate and purposeful colleagues.   Our aim is to have a global impact with sustainable practices.   We are currently looking for: 

Senior Scientist 

Lab Technician

COVID-19 Response

2020.03.24

SARS-CoV-2 Antibody Discovery Strategy

We are joining forces in the war on COVID-19 with a unique open source model. We’re donating our resources to develop custom nanobodies* for others to use in developing diagnostics and therapeutics that have a meaningful impact.

*Trademarked by Ablynx

 
 
NEWS

2020.06.16

Canadian coalition prepares to share research that could help against COVID-19

2020.03.24

Canadian Coalition Fosters Global Collaboration in Fight Against COVID-19

2020.02.19

NovoBind closes Series A, attracts key partners for the next stage of growth

2019.07.01

Lallemand Animal Nutrition and NovoBind Announce Joint Development and Commercialization Agreement for Advanced Salmonella Biologics

 
CONTACT
1021 West Hastings
MNP tower 9th floor,
Vancouver, BC
V6E 0C3, Canada
  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon

©2018 by Novobind Livestock Therapeutics Inc.